Hasn’t legislation been recently introduced to prohibit Authorized Generics during the 180-day exclusivity period?
Related Questions
- Doesn’t the marketing of Authorized Generics offer consumers benefits during the 180-day exclusivity period while preserving the value of patent challenges?
- When have Authorized Generics been launched - prior, during or after the 180-day exclusivity?
- Why has legislation been introduced to provide for another regulatory body?
